.Novo Nordisk has actually axed its once-monthly twin GLP-1/ GIP receptor agonist, finishing (PDF) a...
.Merck & Co. has actually rapidly made back a few of the costs of its Harp on Rehabs purchase, at...
.After BioMarin conducted a springtime clean of its pipe in April, the company has decided that it a...
.Major Pharmas continue to be stuck to the idea of molecular adhesive degraders. The current busines...
.A brand-new global lifestyle science credit rating company, referred to as Symbiotic Resources, has...
.Bristol Myers Squibb is axing an additional big bet coming from the Caforio time, terminating a pac...
.After looking at phase 1 information, Nuvation Bio has actually decided to stop service its own sin...
.Zevra Therapies' uncommon condition drug seems to become on the pathway to approval this loss after...
.Pfizer's phase 3 Duchenne muscle dystrophy (DMD) gene therapy breakdown has actually blown a $230 t...
.After much more than two decades of deal with neurodegenerative ailments, Swiss biotech hvac Immune...